Company | The Mosaic Company |
Ticker | MOS (NYSE) |
Reporting Period | Q2 2026 (quarter ended June 30, 2026) |
Earnings Date | August 5, 2026 — 11:00 AM ET |
Prepared | August 3, 2026 |
Sector ETF Benchmark | XLB (Materials Select Sector SPDR) |
Key Takeaway: The bar is low — consensus EPS for Q2 2026 has collapsed to ~$0.05–0.13 from ~$0.94 a year ago — but the real swing factor is whether phosphate stripping margins have recovered enough to avoid another operating loss, and whether management can provide any clarity on the H2 production outlook after withdrawing full-year phosphate guidance.
Heading into the Q2 2026 print, Mosaic faces a uniquely depressed consensus bar: the street has slashed Q2 EPS estimates from ~$0.94 a year ago to roughly $0.05–0.13, reflecting the Persian Gulf conflict’s devastating impact on global sulfur supply chains that drove an operating loss in Q1 despite record phosphate sales volumes. Management guided Q2 phosphate stripping margins “in excess of $400/tonne” on 60% committed/priced book at $760–780/tonne DAP, with realized sulfur costs of ~$540/tonne — a meaningful sequential improvement from Q1’s ~$379/tonne average that still reflected pre-spike inventory, but the real question is whether spot sulfur has normalized enough to allow production restarts at Bartow and Louisiana. Potash remains the bright spot: Canpotex was sold out through June and on pace for a record 2026, and potash prices have risen sharply since February, which should flow through to Q2/Q3 realizations. The stock is down ~20% since last earnings and trades at just 0.58x book and 6.3x NTM EBITDA — a deeply discounted setup that prices in continued distress — meaning any signal of sulfur normalization or production restart could be a meaningful catalyst. The wildcard is the trajectory of Persian Gulf geopolitics: if refinery damage is more persistent than expected, H2 production curtailments could deepen further, while any ceasefire or supply normalization could trigger a sharp re-rating.
Key Takeaway: Consensus is a very low bar across all KPIs — Q2 EPS of ~$0.05 vs. $0.51 a year ago reflects the depth of the sulfur shock. Phosphate volumes are the bigger swing factor: consensus expects ~1.54M tonnes, well below Q1’s record 1.94M tonnes, as curtailments at Bartow and Louisiana bite. Potash is the relative bright spot with stable volumes and improving price realizations.
KPI | Q1 2026 Actual | Q2 2025 Actual | Q2 2026 Consensus Est. | YoY Change | Q2 2026 Guidance (from Q1 call) | Consensus vs. Guidance |
Adj. EPS (Diluted) | $0.05 | $0.51 | $0.05–$0.13 (mid: ~$0.09) | −82% YoY | No explicit EPS guidance provided | N/A |
Adj. EBITDA | $416M | $566M | ~$393M | −31% YoY | No explicit EBITDA guidance provided | N/A |
Phosphate Sales Volume (KTons) | 1,936 KT | 1,546 KT | ~1,544 KT | −0.1% YoY | 1,400–1,700 KT (mid: 1,550 KT) | −0.4% below mid |
Phosphate Production Volume (KTons) | 1,641 KT | 1,505 KT | ~1,542 KT | +2.5% YoY | Guidance withdrawn; curtailments at Bartow & Louisiana | N/A — guidance withdrawn |
Potash Sales Volume (KTons) | 2,159 KT | 2,343 KT | ~2,099 KT | −10.4% YoY | 1,900–2,100 KT (mid: 2,000 KT); note K-Mag excluded from guidance | +5.0% above mid (incl. K-Mag adj.) |
Mosaic Fertilizantes Adj. EBITDA | $79M | $159M | ~$47M | −70% YoY | Guidance withdrawn due to uncertainty | N/A — guidance withdrawn |
Source: Visible Alpha Consensus and Actuals Data. Q2 2026 consensus estimates as of August 3, 2026. Q2 2026 guidance from Q1 2026 Earnings Release and Earnings Call (May 11, 2026).
Quarter | KPI | Reported | Consensus Est. | Surprise % | Result |
Q1 2026 | Adj. EPS | $0.05 | $0.21 | −76% | MISS |
Q1 2026 | Phosphate Sales Vol. | 1,936 KT | 1,758 KT | +10.1% | BEAT |
Q4 2025 | Adj. EPS | $0.22 | $0.51 | −57% | MISS |
Q4 2025 | Phosphate Sales Vol. | 1,330 KT | 1,392 KT | −4.5% | MISS |
Q3 2025 | Adj. EPS | $1.04 | $0.97 | +7.2% | BEAT |
Q3 2025 | Phosphate Sales Vol. | 1,571 KT | 1,650 KT | −4.8% | MISS |
Q2 2025 | Adj. EPS | $0.51 | $0.70 | −27.1% | MISS |
Q2 2025 | Phosphate Sales Vol. | 1,546 KT | 1,589 KT | −2.7% | MISS |
Q1 2025 | Adj. EPS | $0.49 | $0.46 | +6.5% | BEAT |
Q1 2025 | Phosphate Sales Vol. | 1,498 KT | 1,578 KT | −5.1% | MISS |
Q4 2024 | Adj. EPS | $0.45 | $0.58 | −22.4% | MISS |
Q4 2024 | Phosphate Sales Vol. | 1,622 KT | 1,648 KT | −1.6% | MISS |
Q3 2024 | Adj. EPS | $0.34 | $0.50 | −32.0% | MISS |
Q3 2024 | Phosphate Sales Vol. | 1,475 KT | 1,651 KT | −10.7% | MISS |
Source: Visible Alpha Consensus and Actuals Data.
Pattern: MOS has missed on Adj. EPS in 6 of the last 8 quarters, with misses accelerating in severity as the sulfur shock hit in Q4 2025 and Q1 2026. Phosphate volumes have also missed consensus in 7 of the last 8 quarters, though Q1 2026 was a notable exception (record volumes despite the operating loss). The consistent EPS miss pattern reflects the difficulty of forecasting raw material cost volatility in this environment.
Key Takeaway: Management made sweeping guidance changes at Q1 earnings on May 11 — withdrawing full-year phosphate production guidance and Brazil EBITDA guidance entirely, cutting CapEx by $250M, and providing only Q2 segment-level volume/price guidance. No post-earnings guidance updates have been issued since May 11, leaving the Q2 print as the first opportunity to reset the H2 outlook.
Metric | Initial Guidance (Q1 2026 Earnings Call, May 11, 2026) | Revised Guidance (Post-Earnings) | Current Consensus | Note |
Phosphate Sales Volume (Q2) | 1,400–1,700 KT | — | ~1,544 KT | Reflects partial curtailments at Bartow & Louisiana; consensus at midpoint of range |
Phosphate DAP Price (Q2) | $760–$780/tonne FOB | — | N/A (not tracked separately in VA) | 60% of Q2 book committed and priced at time of Q1 call |
Phosphate Realized Sulfur Cost (Q2) | ~$540/tonne | — | N/A | Up sharply from Q1’s ~$379/tonne; key cost driver to watch |
Phosphate Realized Ammonia Cost (Q2) | ~$610/tonne | — | N/A | Implies Q2 stripping margins >$400/tonne on committed book |
Phosphate Conversion Cost/Tonne (Q2) | Between Q1 actual and ~$105–$110 (H2 target) | — | N/A | Curtailments push fixed cost absorption higher; H2 cost profile ~$105–$110/tonne |
Full-Year Phosphate Production Guidance | WITHDRAWN — reviewing operating plan for rest of year | — | ~6.31M KT (FY) | ↓ Withdrawn at Q1 call due to sulfur availability uncertainty; no update since |
Potash Sales Volume (Q2) | 1,900–2,100 KT (excl. K-Mag) | — | ~2,099 KT | K-Mag (~150–175 KT/qtr) excluded from guidance; Canpotex sold out through June |
Potash MOP Price (Q2) | $260–$280/tonne mine gate | — | N/A | Strong price appreciation since Feb 28 to flow through in Q2/Q3 |
Mosaic Fertilizantes EBITDA (Q2) | WITHDRAWN — uncertainty around nutrient availability | — | ~$47M | ↓ Withdrawn at Q1 call; Brazil nutrient availability and credit constraints cited |
Full-Year CapEx | $1.25B (cut $250M from prior guidance) | — | N/A | ↓ Lowered at Q1 call; deferred less time-sensitive spending; no medium-term production impact |
Full-Year SG&A | $520–$540M | — | N/A | Includes $15M of $50M annualized workforce reduction savings in 2026 |
Working Capital Release (FY 2026) | $300–$500M | — | N/A | Two opposing forces: higher raw material costs reduce release; curtailments increase it |
Source: MOS Q1 2026 Earnings Release and Earnings Call Transcript (May 11, 2026); MOS 8-K (June 15, 2026).
Key Takeaway: Estimates have been in freefall since Q1 earnings — Q2 EPS consensus has collapsed from $0.21 (post-Q1 baseline) to ~$0.05 today, a ~76% cut in under three months. FY 2026 EPS consensus has fallen from $0.78 to $0.63, reflecting the market’s view that H2 will not fully recover from the sulfur shock. The gap between withdrawn guidance and current consensus creates maximum uncertainty heading into the print.
KPI (Period) | Estimate ~5 Days Post Q1 Earnings (as of ~May 18, 2026) | Current Consensus (Aug 3, 2026) | Estimate Δ (%) | Initial Guidance (Q1 Call, May 11) | Current Guidance | Guidance Δ | Consensus vs. Guidance (%) |
Adj. EPS — Q2 2026 | $0.21 | $0.05 | −76% | No explicit guidance | No explicit guidance | N/A | N/A |
Adj. EPS — FY 2026 | $0.78 | $0.63 | −19% | No explicit guidance | No explicit guidance | N/A | N/A |
Adj. EBITDA — Q2 2026 | $437M | $393M | −10% | No explicit guidance | No explicit guidance | N/A | N/A |
Adj. EBITDA — FY 2026 | $1,738M | $1,659M | −5% | No explicit guidance | No explicit guidance | N/A | N/A |
Phosphate Sales Vol. — Q2 2026 | 1,549 KT | 1,544 KT | −0.3% | 1,400–1,700 KT (mid: 1,550 KT) | Unchanged | N/A | −0.4% vs. mid |
Phosphate Sales Vol. — FY 2026 | 6,665 KT | 6,480 KT | −2.8% | Guidance withdrawn | Guidance withdrawn | N/A | N/A |
Potash Sales Vol. — Q2 2026 | 2,049 KT | 2,099 KT | +2.4% | 1,900–2,100 KT (excl. K-Mag) | Unchanged | N/A | +5.0% above mid (incl. K-Mag adj.) |
Mosaic Fertilizantes EBITDA — Q2 2026 | $56M | $47M | −16% | Guidance withdrawn | Guidance withdrawn | N/A | N/A |
Source: Visible Alpha Consensus and Actuals Data. Post-Q1 baseline as of approximately May 18, 2026 (5 trading days after May 11, 2026 earnings). Current consensus as of August 3, 2026.
The estimate revision trajectory tells a stark story: the street has been cutting numbers continuously since Q1 earnings, with EPS estimates down 76% for Q2 and 19% for FY 2026. Notably, phosphate volume estimates have been relatively stable (down only ~0.3% for Q2), suggesting the market is not expecting further curtailment surprises on the volume side — the risk is entirely on the cost/margin side. The absence of any company guidance for EBITDA or EPS creates a wide range of outcomes, and the Q2 print will be the first opportunity to reset expectations for H2.
Key Takeaway: MOS is up only ~1.5% since Q1 earnings (May 11, 2026) vs. XLB −13.5% and SPY +1.0% — a modest relative outperformance driven almost entirely by multiple expansion on collapsing earnings estimates rather than fundamental improvement. Over 12 months, MOS is down ~39%, with the decline almost entirely earnings-driven (P/Book compressed from 0.92x to 0.58x), reflecting the market’s loss of confidence in the earnings power of the phosphate franchise.
MOS vs. XLB (Materials Select Sector SPDR) vs. S&P 500 — Indexed to 100 at Q1 2026 Earnings (May 11, 2026). MOS +1.5%, XLB ∓3.5%, SPY +1.0% through August 4, 2026. Source: Yahoo Finance.
Performance decomposition: Over the past 12 months, MOS has declined ~39%, with the move almost entirely driven by earnings estimate compression rather than multiple contraction — P/E has actually expanded from 11.4x to 16.6x NTM as EPS estimates collapsed faster than the stock price fell. P/Book has compressed from 0.92x to 0.58x, reflecting the market’s view that book value itself may be impaired. Since Q1 earnings, the stock has traded in a tight $19.82–$24.06 range, with a brief dip to $19.82 on June 10 (likely on macro/geopolitical concerns) before recovering. The stock is essentially pricing in a prolonged period of below-normal earnings, with any sulfur normalization representing significant upside optionality.
Key Takeaway: The most important post-Q1 development is the $1B credit facility secured on June 10, 2026, which removes near-term liquidity risk and signals management’s confidence in navigating the downturn. No operational guidance updates have been issued since Q1 earnings, leaving the Q2 print as the first opportunity to reset the H2 outlook.
Key Takeaway: No open-market buys or discretionary sells were recorded in the period. All transactions on May 28, 2026 were routine director compensation grants (transaction code “M” — exercise/conversion of equity awards), not open-market purchases or sales. No meaningful insider signal either way.
Name | Title | Transaction Type | Shares | Date | Note |
Beebe, Cheryl K. | Director | Equity Award Conversion (Code M) | 2,437 | May 28, 2026 | Routine director compensation; not an open-market transaction |
Ebel, Gregory L. | Director | Equity Award Conversion (Code M) | 7,310 | May 28, 2026 | Routine director compensation; not an open-market transaction |
Gitzel, Timothy S. | Director | Equity Award Conversion (Code M) | 4,873 | May 28, 2026 | Routine director compensation; not an open-market transaction |
Koenig, Emery N. | Director | Equity Award Conversion (Code M) | 4,873 | May 28, 2026 | Routine director compensation; not an open-market transaction |
Kuzenko, Jody Lynne | Director | Equity Award Conversion (Code M) | 4,873 | May 28, 2026 | Routine director compensation; not an open-market transaction |
Little, Sonya C. | Director | Equity Award Conversion (Code M) | 4,873 | May 28, 2026 | Routine director compensation; not an open-market transaction |
Seaton, David Thomas | Director | Equity Award Conversion (Code M) | 3,167 | May 28, 2026 | Routine director compensation; not an open-market transaction |
Shanahan, Kathleen M. | Director | Equity Award Conversion (Code M) | 4,873 | May 28, 2026 | Routine director compensation; not an open-market transaction |
Teixeira, Joao Roberto G. | Director | Equity Award Conversion (Code M) | 4,873 | May 28, 2026 | Routine director compensation; not an open-market transaction |
Watkins, Gretchen H. | Director | Equity Award Conversion (Code M) | 4,873 | May 28, 2026 | Routine director compensation; not an open-market transaction |
Westbrook, Kelvin R. | Director | Equity Award Conversion (Code M) | 2,437 | May 28, 2026 | Routine director compensation; not an open-market transaction |
Source: SEC Form 4 Filings (filed June 1, 2026; transactions dated May 28, 2026). All transactions are Code M (exercise/conversion of equity awards) — routine director compensation grants, not open-market buys or sells. No open-market purchases (Code P) or sales (Code S) were recorded in the period. No 10b5-1 plan initiations disclosed.
Key Takeaway: Peer commentary from the past 60 days paints a mixed but directionally cautious picture for MOS’s Q2 2026 print. ICL’s raised FY 2026 guidance is the most directly positive read-through — a potash/phosphate peer seeing enough improvement to lift its full-year outlook. However, FMC and Corteva both flag a persistently challenging macro environment, strained farmer margins, and continued pricing pressure in Brazil and North America that are headwinds for MOS’s distribution business. The net read is: potash demand is healthy, but the broader agricultural input environment remains difficult, and Brazil credit/nutrient availability constraints are real.
Methodology: Only commentary published between June 3 and August 3, 2026 (past 60 days) that pertains to MOS’s Q2 2026 current reporting period or near-term forward outlook is included. Prior-quarter retrospective commentary (e.g., peers discussing their own Q1 2026 results without forward-looking content) has been excluded. Each read-through is labeled Direct (clearly applicable to MOS’s business) or Indirect (broader market signal with less direct applicability).
Relevance: ICL is a direct phosphate and potash peer with overlapping end markets. The July 30 filing contains forward-looking FY 2026 guidance and strategic commentary.
Source: ICL Group 6-K filed July 30, 2026.
Relevance: Corteva is a leading crop protection and seed company with deep exposure to the same farmer end markets as MOS. Its Q2 2026 commentary provides real-time color on farmer purchasing behavior, Brazil conditions, and the global agricultural backdrop.
Source: Corteva Q2 2026 Earnings Call Transcript (July 31, 2026); Corteva Q2 2026 Earnings Release (July 30, 2026).
Relevance: FMC is a global crop protection company with significant Brazil and North America exposure. Its Q2 2026 commentary provides the most detailed and cautious read on current farmer purchasing behavior and the macro agricultural environment.
Source: FMC Corporation Q2 2026 Earnings Call Transcript (July 30, 2026); FMC Corporation Q2 2026 Earnings Release (July 29, 2026).
Peer | Date | Key Read-Through for MOS Q2 2026 | Type | Direction |
ICL Group | Jul 30, 2026 | Raised FY 2026 EBITDA guidance to $1.5B–$1.7B; potash/phosphate peer seeing improving conditions | Direct | Positive |
ICL Group | Jul 30, 2026 | Strategic focus on maximizing Potash business; signals conviction in potash market fundamentals | Direct | Positive |
Corteva | Jul 31, 2026 | Farmer margins tight globally; cautious on discretionary spending | Direct | Negative |
Corteva | Jul 31, 2026 | Brazil credit tight; farmers wrestling with higher interest rates and currency issues; fertilizer prices stressing margins | Direct | Negative |
Corteva | Jul 31, 2026 | Brazil corn acreage flat in H2 2026; potential flattening in 2027 | Direct | Negative |
Corteva | Jul 31, 2026 | Global grain/oilseed demand very strong; crop prices up YoY — supportive long-term fundamentals | Direct | Positive |
Corteva | Jul 31, 2026 | Raised FY 2026 EBITDA guidance; confidence in H2 2026 | Indirect | Positive |
FMC | Jul 30, 2026 | Growers facing high fertilizer + fuel costs; carefully managing spending | Direct | Negative |
FMC | Jul 30, 2026 | Q2 challenging conditions expected to persist in Q3; no major change in Q4 | Direct | Negative |
FMC | Jul 30, 2026 | North America: strained farmer margins; distributors shifting orders Q3→Q4 | Direct | Negative (Q3) |
FMC | Jul 30, 2026 | Brazil: healthy Q4 volume growth expected; direct sales to growers increasing | Direct | Positive (Q4) |
FMC | Jul 30, 2026 | Expects lower raw material costs in Q4 2026 | Direct | Positive (Q4) |
FMC | Jul 30, 2026 | Lowered FY 2026 EBITDA guidance ~23%; challenging operating environment | Indirect | Negative |
Note on excluded commentary: Nutrien (NTR) has not yet reported Q2 2026 results (earnings date not yet confirmed as of August 3, 2026). NTR’s Q2 2026 earnings would be the most directly relevant peer read-through given its near-identical phosphate and potash business mix, but no current-quarter commentary was available within the 60-day window. The Canaccord Genuity (CF CN) Q4 FY2026 earnings call (June 4, 2026) was excluded as it pertained to a different fiscal period and company (Canadian financial services, not CF Industries). SMG (Scotts Miracle-Gro) commentary was not available in the research window.
Net read-through assessment: The peer commentary is net cautious for MOS’s Q2 2026 print. The positive signals (ICL guidance raise, Corteva’s strong global demand commentary) are more relevant to the long-term outlook and potash segment, while the negative signals (FMC’s persistent challenging conditions, Corteva’s Brazil credit/acreage concerns) are more directly relevant to MOS’s near-term phosphate and Fertilizantes performance. The most actionable read-through is FMC’s expectation of lower raw material costs in Q4 — if sulfur costs are indeed easing, MOS’s H2 guidance could be less dire than feared.